Holmium laser enucleation of prostate for XXXX : seoul national university hospital experience.

@entity1 @entity1067 @entity3142
PURPOSE: The objective of this study was to report the experience acquired at the Seoul National University Hospital with Holmium Laser Enucleation of Prostate (HoLEP), combined with mechanical morcellation for symptomatic @entity1067 ( @entity1067 ). METHODS: A retrospective review was performed on the clinical data of 309 consecutive @entity1 who underwent HoLEP at our institution between July 2008 and June 2010. All @entity1 were evaluated preoperatively for prostate volume by transrectal ultrasound, maximum urinary flow rate (Qmax), International Prostate Symptoms Score (IPSS) and quality of life (QoL) score. Peri- and postoperative parameters were evaluated and @entity1 were followed-up at 1-, 3-, 6-, and 12- months with the aforementioned investigations. RESULTS: The @entity1 ' mean age was 68.3 (  6.5) years and mean prostate volume was 55.6 (  23.6) mL. Mean enucleation time was 56.2 (  25.1) minutes, mean morcellation time was 11.3 (  9.5) minutes, and the mean resected weight of the prostate was 20.8 (  16.9) g. The mean catheter indwelling period was 1.9 (  1.7) days and mean hospital stay was 2.9 (  1.5) days. Significant improvement was noted in Qmax, IPSS, and QoL at the 1-year follow-up compared with baseline (P<0.01). At 1 month 17.2% of @entity1 complained of irritative urinary symptoms, which were typically self-limiting within 3 months. Transient @entity3142 was reported in 15.2% of @entity1 . No @entity1 experienced persistent obstructive symptoms that required reoperation. CONCLUSIONS: Our study showed that HoLEP is a safe and effective therapeutic modality for @entity1067 .
